WO2002099062A3 - Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use - Google Patents

Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use Download PDF

Info

Publication number
WO2002099062A3
WO2002099062A3 PCT/US2002/017559 US0217559W WO02099062A3 WO 2002099062 A3 WO2002099062 A3 WO 2002099062A3 US 0217559 W US0217559 W US 0217559W WO 02099062 A3 WO02099062 A3 WO 02099062A3
Authority
WO
WIPO (PCT)
Prior art keywords
bind
nucleic acids
methods
antigens
acids encoding
Prior art date
Application number
PCT/US2002/017559
Other languages
French (fr)
Other versions
WO2002099062A2 (en
Inventor
David W Anderson
Bryan D Zerhusen
Li Li
Mei Zhong
Stacie J Casman
Original Assignee
Curagen Corp
David W Anderson
Bryan D Zerhusen
Li Li
Mei Zhong
Stacie J Casman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/161,493 external-priority patent/US20040018555A1/en
Application filed by Curagen Corp, David W Anderson, Bryan D Zerhusen, Li Li, Mei Zhong, Stacie J Casman filed Critical Curagen Corp
Priority to CA002447935A priority Critical patent/CA2447935A1/en
Priority to JP2003502172A priority patent/JP2005506833A/en
Priority to EP02732027A priority patent/EP1401470A4/en
Publication of WO2002099062A2 publication Critical patent/WO2002099062A2/en
Publication of WO2002099062A3 publication Critical patent/WO2002099062A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

Disclosed herein are nucleic acid sequences that encode polypeptides. Also disclosed are antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids, polypeptides, or antibodies, or fragments thereof.
PCT/US2002/017559 2001-06-04 2002-06-04 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use WO2002099062A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002447935A CA2447935A1 (en) 2001-06-04 2002-06-04 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
JP2003502172A JP2005506833A (en) 2001-06-04 2002-06-04 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding antigens, and methods of use
EP02732027A EP1401470A4 (en) 2001-06-04 2002-06-04 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US29560701P 2001-06-04 2001-06-04
US60/295,607 2001-06-04
US29641801P 2001-06-06 2001-06-06
US29640401P 2001-06-06 2001-06-06
US60/296,404 2001-06-06
US60/296,418 2001-06-06
US29657501P 2001-06-07 2001-06-07
US60/296,575 2001-06-07
US29741401P 2001-06-11 2001-06-11
US60/297,414 2001-06-11
US29756701P 2001-06-12 2001-06-12
US29757301P 2001-06-12 2001-06-12
US60/297,567 2001-06-12
US60/297,573 2001-06-12
US29828501P 2001-06-14 2001-06-14
US60/298,285 2001-06-14
US29852801P 2001-06-15 2001-06-15
US29855601P 2001-06-15 2001-06-15
US60/298,556 2001-06-15
US60/298,528 2001-06-15
US29913301P 2001-06-18 2001-06-18
US60/299,133 2001-06-18
US29923001P 2001-06-19 2001-06-19
US60/299,230 2001-06-19
US29994901P 2001-06-21 2001-06-21
US60/299,949 2001-06-21
US30017701P 2001-06-22 2001-06-22
US60/300,177 2001-06-22
US30155001P 2001-06-28 2001-06-28
US30153001P 2001-06-28 2001-06-28
US60/301,530 2001-06-28
US60/301,550 2001-06-28
US30295101P 2001-07-03 2001-07-03
US60/302,951 2001-07-03
US31877101P 2001-09-12 2001-09-12
US60/318,771 2001-09-12
US32468701P 2001-09-25 2001-09-25
US60/324,687 2001-09-25
US32568501P 2001-09-27 2001-09-27
US33926601P 2001-10-24 2001-10-24
US60/339,266 2001-10-24
US33752401P 2001-11-16 2001-11-16
US60/337,524 2001-11-16
US34114301P 2001-12-14 2001-12-14
US60/341,143 2001-12-14
US35915102P 2002-02-21 2002-02-21
US35864302P 2002-02-21 2002-02-21
US60/358,643 2002-02-21
US60/359,151 2002-02-21
US36119502P 2002-02-28 2002-02-28
US60/361,195 2002-02-28
US36196402P 2002-03-05 2002-03-05
US60/361,964 2002-03-05
US37134602P 2002-04-10 2002-04-10
US37152302P 2002-04-10 2002-04-10
US60/371,523 2002-04-10
US60/371,346 2002-04-10
US10/161,493 2002-06-03
US10/161,493 US20040018555A1 (en) 2001-06-04 2002-06-03 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use

Publications (2)

Publication Number Publication Date
WO2002099062A2 WO2002099062A2 (en) 2002-12-12
WO2002099062A3 true WO2002099062A3 (en) 2003-02-20

Family

ID=27586880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/017559 WO2002099062A2 (en) 2001-06-04 2002-06-04 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use

Country Status (1)

Country Link
WO (1) WO2002099062A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129085B2 (en) 2001-10-11 2006-10-31 Bristol-Myers Squibb Company Polynucleotides encoding a human leucine-rich repeat domain containing protein, HLLRCR-1
AU2003234717A1 (en) 2002-04-12 2003-10-27 Bristol-Myers Squibb Company Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
PL375356A1 (en) * 2002-05-20 2005-11-28 Immunex Corporation Claudin polypeptides, polynucleotides, and methods of making and use thereof
GB0219776D0 (en) * 2002-08-24 2002-10-02 Oxford Glycosciences Uk Ltd A protein involved in carcinoma
US7547518B2 (en) * 2003-08-19 2009-06-16 Becton, Dickinson And Company Method of screening endothelial cells for angiogenic capability
CN104655854A (en) 2008-04-09 2015-05-27 健泰科生物技术公司 Novel compositions and methods for the treatment of immune related diseases
TWI538685B (en) 2010-04-02 2016-06-21 腫瘤療法 科學股份有限公司 Ect2 peptides and vaccines including the same
KR101843248B1 (en) * 2015-03-17 2018-03-29 고려대학교 세종산학협력단 Peptide derivatives controlling thymic stromal lymphoprotein mediated signal transduction, and pharmaceutical composition for prevention and treatment of allergy and asthma comprising the peptide derivatives
WO2019155075A1 (en) * 2018-02-09 2019-08-15 Metabolomic Diagnostics Limited Methods of predicting pre term birth from preeclampsia using metabolic and protein biomarkers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06211898A (en) * 1992-12-25 1994-08-02 Takara Shuzo Co Ltd Neural alpha-catenin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06211898A (en) * 1992-12-25 1994-08-02 Takara Shuzo Co Ltd Neural alpha-catenin
US5470966A (en) * 1992-12-25 1995-11-28 Takara Shuzo Co., Ltd. Neural α-catenin

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CELL, vol. 70, no. 2, 1992, pages 293 - 301 *
DATABASE GENBANK [online] 3 February 1999 (1999-02-03), HICANO S. ET AL.: "Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization", XP002957410, Database accession no. (BAA01863 *
DATABASE PROTEIN [online] 13 August 1999 (1999-08-13), UCHIDA N. ET AL.: "Mouse alpha N-catenin: two isoforms, specific expression in the nervous system and chromosomal localization of the gene", XP002954994, Database accession no. (I49500) *
DATABASE PROTEIN [online] 13 August 1999 (1999-08-13), UCHIDA N. ET AL.: "Mouse alpha N-catenin: two isoforms, specific expression in the nervous system and chromosomal localization of the gene", XP002957407, Database accession no. (I49499) *
DATABASE PROTEIN [online] 17 March 2000 (2000-03-17), CLAVERIE J.M. ET AL.: "Characterization and chromosomal assigment of a human cDNA encoding a protein related to the murine 102-KDA cadherin-associated protein (alpha-catenin)", XP002957411, Database accession no. (A45011) *
DEV. BIOL., vol. 1, no. 163, 1994, pages 75 - 85 *
GENOMICS, vol. 15, no. 1, 1993, pages 13 - 20 *

Also Published As

Publication number Publication date
WO2002099062A2 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
WO2002014368A3 (en) Proteins and nucleic acids encoding the same
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002064791A3 (en) Proteins and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2001060990A3 (en) Sphingosine kinases
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002081625A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
WO2002029038A3 (en) Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002010216A3 (en) Proteins and nucleic acids encoding same
WO2002055702A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002099062A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same
WO2002079398A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002066643A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002099116A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002090504A3 (en) Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002303960

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2447935

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003502172

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002732027

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002732027

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002732027

Country of ref document: EP

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)